Old Web
English
Sign In
Acemap
>
authorDetail
>
Marianne M. Stanford
Marianne M. Stanford
Halifax
Immune system
Medicine
Cancer vaccine
Cancer
Cyclophosphamide
4
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE1 trial): T cell responses and tumor infiltration correlate with tumor regression.
2019
Journal of Clinical Oncology
Janos L. Tanyi
Oliver Dorigo
Amit M. Oza
James Strauss
Tanja Pejovic
Sharad A. Ghamande
Prafull Ghatage
Jeannine Villella
Stephan Fiset
Lisa Diana MacDonald
Olga Hrytsenko
Marianne M. Stanford
Robert C. Newton
Lance Leopold
Gabriela Nicola Rosu
Show All
Source
Cite
Save
Citations (0)
Using MRI cell tracking to monitor immune cell recruitment in response to a peptide‐based cancer vaccine
2018
Magnetic Resonance in Medicine
Marie-Laurence Tremblay
Christa Davis
Chris V. Bowen
Olivia Stanley
Cathryn Parsons
Genevieve Mary Weir
Mohan Karkada
Marianne M. Stanford
Kimberly D. Brewer
Show All
Source
Cite
Save
Citations (5)
Using MRI cell tracking to monitor immune cell recruitment in response to a peptide-based cancer vaccine.
2018
Magnetic Resonance in Medicine
Marie-Laurence Tremblay
Christa Davis
Chris V. Bowen
Olivia Stanley
Cathryn Parsons
Genevieve Mary Weir
Mohan Karkada
Marianne M. Stanford
Kimberly D. Brewer
Show All
Source
Cite
Save
Citations (21)
Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide
2016
Journal for ImmunoTherapy of Cancer
Genevieve Weir
Olga Hrytsenko
Tara Quinton
Neil L. Berinstein
Marianne M. Stanford
Marc Mansour
Show All
Source
Cite
Save
Citations (19)
1